Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis
AUTOR(ES)
Greenberg, Jeffrey D.
FONTE
Oxford University Press
RESUMO
Objectives. To evaluate composite measures of response without acute-phase reactants in RA patients. Specifically, Clinical Disease Activity Index (CDAI)-derived response criteria were compared with the European League Against Rheumatism (EULAR) response criteria, and the modified ACR (mACR) response criteria were compared to the ACR response criteria.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2722796Documentos Relacionados
- Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue
- Albumin synthesis rates in cachectic cancer patients with an ongoing acute-phase protein response.
- Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.
- Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level.
- Relationship between genetic mutation variations and acute-phase reactants in the attack-free period of children diagnosed with familial Mediterranean fever